Cocrystal Discovery Lands $7,500,000 New Funding Round

  • Feed Type
  • Date
    9/15/2011
  • Company Name
    Cocrystal Discovery
  • Mailing Address
    19805 North Creek Parkway Bothell, WA 98011
  • Company Description
    Cocrystal Discovery, Inc. is a privately funded biotechnology company developing antiviral therapeutics for human diseases. Cocrystal has breakthrough technologies that enable the creation of first- and best-in-class antivirals. Our mission today is to discover and develop small molecule inhibitors of the viral replication complex. Viral diseases represent one of the world’s largest and greatest unmet medical needs. We are currently focusing on: Hepatitis C virus, Influenza virus, Rhinovirus (common cold).
  • Website
    http://www.cocrystaldiscovery.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This investment will be utilized by CDI to continue its development program of novel antiviral drugs that target viral replication enzymes.
  • M&A Terms
  • Venture Investor
    Teva Pharmaceutical Industries